Read Full Article
"We are very pleased to welcome Mr. Smith and Dr. Kumar to our board," said ... Dr. Kumar has also served on scientific advisory boards in the fields of ...
We are very pleased to welcome Mr. Smith and Dr. Kumar to our board.
Titan has an opportunity to make a significant contribution to the treatment of certain chronic diseases with its ProNeura platform. The commercialization of Probuphine, along with the development of ProNeura for Parkinson's disease and hypothyroidism, represent the beginning of what promises to be an important portfolio of product candidates.
Despite important advances in drug development, effective and convenient drug delivery remains an unmet challenge. Many patients suffer from side effects associated with inconsistent levels of medication in the blood and struggle with compliance.